Moonwalk Biosciences

Moonwalk Biosciences is a biotechnology company dedicated to pioneering a new class of precision epigenetic medicines. They aim to reprogram cells back to their healthy state by targeting the "software" of the genome, the epigenetic code, rather than directly altering the DNA sequence. Their platform technology, EpiRead and EpiWrite, combines comprehensive epigenetic profiling with precise engineering tools. This allows for the mapping of the epigenome at a single cell level, and the development of targeted epigenetic therapies for a range of complex diseases.

Moonwalk is an early-stage company with a world-class team of scientists and industry leaders. Co-founded by Alex Aravanis, M.D., Ph.D., former CTO of Illumina, and world-renowned scientist Feng Zhang, Ph.D., of the Broad Institute of MIT and Harvard, Moonwalk has raised significant funding from leading life sciences investors. Their focus is on developing safe and durable epigenetic medicines that address the root causes of disease, with an initial focus on cardiometabolic diseases.

Moonwalk Biosciences is a preclinical-stage biotechnology company dedicated to pioneering precision epigenetic medicines. They aim to reprogram cells back to their healthy state by targeting the epigenetic code, the software of the genome, fundamentally changing how therapies are discovered and developed. Moonwalk's innovative platform combines comprehensive epigenome profiling with precise engineering tools, enabling them to develop potentially curative treatments for various diseases by addressing the root cause. Their focus on epigenetic engineering leverages read-and-write technologies to create safer and more effective treatments for a broad range of diseases, without altering the underlying DNA sequence.

Moonwalk Biosciences promotes a collaborative and innovative work culture. The company emphasizes teamwork and encourages employees to clearly articulate their ideas and solutions. They are dedicated to developing groundbreaking scientific advancements in a supportive environment that thrives on demanding schedules and pushing the boundaries of what's possible in epigenetic engineering. The company values diversity of thought and welcomes individuals who are passionate, talented, and committed to advancing the field of epigenetic medicine.

Moonwalk Biosciences values diverse perspectives as fundamental to scientific innovation. They are committed to building a team of exceptional scientists and industry leaders from various backgrounds, working together to advance their shared mission. They explicitly state that they are an Equal Opportunity Employer and prohibit any form of discrimination or harassment based on race, color, religion, age, sex, national origin, disability status, genetics, protected veteran status, sexual orientation, gender identity or expression, or any other characteristic protected by law.